Go to the list of all blogs
Serhii Bondarenko's Avatar
published in Blogs
Jul 20, 2026
Crown Holdings (CCK) Rises +15.4% in 30 Days: Earnings Momentum Builds

Crown Holdings (CCK) Rises +15.4% in 30 Days: Earnings Momentum Builds

Key Takeaways

  • Crown Holdings (CCK) gained approximately 15.4% over the last 30 days, climbing from $101.54 on June 18 to $117.21 by July 17, 2026.
  • A breakout above the prior 52-week high of $116.62 and a Raymond James price-target increase to $135 fueled bullish momentum.
  • First-quarter 2026 results exceeded expectations, with adjusted EPS of $1.86 on revenue of $3.26 billion, reinforcing confidence ahead of Q2 earnings.
  • JPMorgan's upgrade to Overweight in May and a broader consensus of Moderate Buy from analysts supported the upward trajectory.
  • Q2 2026 earnings are due after market close on July 20, with consensus estimates forecasting EPS of $2.15 and revenue of approximately $3.35 billion.
  • Record 2025 free cash flow of $1.146 billion and net leverage reduced to 2.5x underscore improving balance-sheet strength.

Crown Holdings (CCK) Company Overview and Market Position

CCK is one of the world's leading manufacturers of rigid packaging products, primarily aluminum beverage cans, and also produces food cans, aerosol cans, metal closures, and specialty packaging solutions. Headquartered in Tampa, Florida, and founded in 1919, Crown operates across the Americas, Europe, the Middle East, North Africa, and Asia-Pacific, serving multinational beverage companies and regional producers alike. The company's extensive manufacturing footprint, long-term supply agreements with blue-chip customers, and exposure to secular sustainability trends favoring infinitely recyclable aluminum packaging provide durable competitive advantages. Investors follow CCK closely as a proxy for global beverage consumption and packaging-industry health, while also monitoring aluminum costs, energy prices, and macroeconomic demand signals.

CCK Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 calendar days, CCK shares rallied from a closing price of $101.54 on June 18, 2026, to $117.21 on July 17, 2026 — an increase of approximately 15.4%. The move accelerated sharply in the final two weeks of the period, with a notable 4.9% single-day surge on July 16 that pushed the stock decisively through its prior 52-week high of $116.62, establishing fresh multi-year highs. Volume on that breakout day reached approximately 1.08 million shares, roughly in line with the 90-day average, signaling broad-based participation rather than a low-conviction spike.

Looking at the trailing quarter, CCK has climbed approximately 12.5% from its April 20 close of $104.22. The path was not linear: the stock pulled back meaningfully in late April and early May, dipping to an intra-quarter trough near $92 in early June before staging a sharp recovery. The V-shaped recovery pattern reflected a combination of post-earnings digestion, macroeconomic repositioning, and renewed analyst conviction that drove momentum into July. The stock's 50-day moving average crossed firmly above its 200-day moving average during the period, reinforcing the bullish technical picture.

Catalysts Behind the Recent 30-Day Advance

Several catalysts converged to drive CCK's 15.4% advance. The most immediate spark came on July 15, when Raymond James raised its price target on Crown Holdings to $135 from $125 while reiterating an Outperform rating. The analyst note highlighted Crown's favorable positioning for 2026 growth via North America strength, potential Asia outperformance, and constructive Southern Europe exposure. Combined with the stock already trading near 52-week highs, the revised target galvanized buying interest and helped push CCK through technical resistance.

Underpinning the move was a growing anticipation of Crown's Q2 2026 earnings report, scheduled for release after the market close on July 20. The company guided Q2 adjusted EPS to a range of $2.10–$2.20, and consensus estimates settled around $2.15 on revenue of roughly $3.35 billion. Crown's track record of beating estimates — including a $0.11 EPS beat in Q1 on revenue that surpassed forecasts by $230 million — added credibility to the bullish narrative. The Q1 report also featured 5% global beverage shipment growth and a reaffirmation of full-year EPS guidance of $7.90–$8.30, signaling management confidence in sustained demand.

Earlier in the quarter, JPMorgan upgraded CCK from Neutral to Overweight in May, citing a tightening supply-demand balance in the beverage can industry. That call, combined with Weiss Ratings maintaining a B- (Buy) rating and Truist Securities reiterating its Buy at $129, contributed to a broadening institutional endorsement. The analyst consensus stood at Moderate Buy with an average target price of approximately $120, providing valuation support even as the stock appreciated.

On the macro side, easing aluminum input-cost pressures and declining resin prices provided a tailwind for margins, while the secular shift toward sustainable, recyclable packaging continued to favor aluminum can demand over plastic alternatives. Crown's improving balance sheet — with net leverage declining to 2.5x from 2.7x and record adjusted free cash flow of $1.146 billion posted in fiscal 2025 — gave investors additional confidence in the company's ability to navigate cost volatility. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Factors Influencing Performance Over the Quarter

Crown Holdings' quarterly performance was shaped by a powerful earnings-driven recovery and improving sentiment around the packaging sector. After Q1 2026 results posted in late April demonstrated double-digit revenue growth (up 12.9% year-over-year) and a convincing EPS beat, the stock initially pulled back as broader market caution and commodity-related concerns weighed on industrials. The stock found a bottom near $92 in early June before a sustained rally took hold. The turning point coincided with several analyst actions: JPMorgan's Overweight upgrade, Bank of America's reaffirmed Buy rating at $126, and Deutsche Bank's initiation with a Buy and $124 target. Concurrently, the packaging sector as a whole gained roughly 6% following Q1 reporting season, according to Raymond James, with beverage can manufacturers seen as particularly well-positioned given resilient global demand and constrained capacity. Crown's record 2025 financial performance — including record adjusted EBITDA of approximately $2.1 billion and a 22% jump in adjusted diluted EPS to $7.79 — provided the fundamental backdrop that made the stock attractive when it traded at discounted levels.

Exploring AI Tools for Market Insights

In my research process, I sometimes review Tickeron's Trending AI Robots page to get a curated view of top-performing automated trading strategies. This section surfaces bots with the strongest real-time performance across momentum, swing, and trend-following approaches, complete with transparent historical metrics, win rates, and drawdown statistics. It helps quickly identify algorithmic strategies aligned with current market conditions without manually sorting through the full marketplace.

What to Watch for in the CCK Stock Forecast

The most immediate catalyst for CCK is the Q2 2026 earnings report and subsequent conference call on July 21. Investors will scrutinize whether adjusted EPS lands within or above the $2.10–$2.20 guided range, Americas Beverage segment volumes, and any updates to full-year 2026 guidance. Management's commentary on North American capacity tightness, Brazilian demand recovery, and the $0.05 inflationary headwind embedded in second-half guidance related to Middle East freight and energy costs will be closely parsed. Beyond earnings, aluminum price trends, global beverage consumption patterns, and any shifts in trade policy or tariffs affecting packaging supply chains remain key macro variables. Competitive dynamics with peers such as BALL and OI also warrant monitoring, as capacity decisions across the industry influence pricing and margin outlooks. While analyst sentiment remains broadly constructive, the stock's rapid appreciation to fresh highs may raise expectations for flawless execution in upcoming quarters.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CCK

Contributor

Serhii Bondarenko is an AI-focused trading strategist and financial markets analyst specializing in the development and application of AI trading bots and autonomous trading agents. His work combines technical analysis, fundamental analysis, and quantitative research to identify market patterns, forecast price movements, and analyze liquidity, volatility, and correlations across global stock markets. Serhii actively publishes market insights, forecasts, and trading frameworks on platforms such as Investing.com and Finextra, with a strong focus on AI-driven decision-making and next-generation algorithmic trading. His research aims to bridge the gap between traditional trading methodologies and advanced artificial intelligence, helping traders and investors navigate complex and rapidly evolving market conditions.


CCK in +1.89% Uptrend, advancing for three consecutive days on August 05, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CCK advanced for three days, in of 317 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 50-day moving average for CCK moved above the 200-day moving average on July 13, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 218 cases where CCK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CCK moved out of overbought territory on July 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 61 cases where CCK's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on August 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCK as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CCK turned negative on August 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CCK broke above its upper Bollinger Band on July 16, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CCK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.579) is normal, around the industry mean (6.715). P/E Ratio (17.368) is within average values for comparable stocks, (30.302). Projected Growth (PEG Ratio) (0.637) is also within normal values, averaging (0.964). CCK has a moderately low Dividend Yield (0.011) as compared to the industry average of (0.031). P/S Ratio (1.029) is also within normal values, averaging (1.304).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock better than average.

Industry description

The containers/packing sector includes companies that manufacture containers (like plastic and aluminum food containers, glass bottles, metal cans, cardboard, storage and waste bags, giftwraps etc.) and provide packing services. Food-and-beverage and household products are major markets for this business. Several companies in this industry cater to international markets in addition to serving domestic customers. Consumer spending habits could potentially affect this industry’s performance. Some products, that use oil-based materials as inputs, are likely to see their costs of production get impacted (to some extent) by energy price movements. The ever-expanding e-commerce market has only supercharged the amount/frequency of goods shipped domestically and across borders, thereby creating ample potential opportunities for containers and packaging businesses. Ball Corporation, International Paper Company, Amcor Plc and Packaging Corporation of America are some of the largest U.S. companies in this industry.

Market Cap

The average market capitalization across the Containers/Packaging Industry is 7.66B. The market cap for tickers in the group ranges from 6.74K to 66.8B. STO holds the highest valuation in this group at 66.8B. The lowest valued company is EPTI at 6.74K.

High and low price notable news

The average weekly price growth across all stocks in the Containers/Packaging Industry was -0%. For the same Industry, the average monthly price growth was 7%, and the average quarterly price growth was 2%. KRT experienced the highest price growth at 14%, while OI experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Containers/Packaging Industry was -20%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 56
Price Growth Rating: 49
SMR Rating: 71
Profit Risk Rating: 82
Seasonality Score: -27 (-100 ... +100)
View a ticker or compare two or three
CCK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which engages in designing, manufacturing of steel and aluminum cans

Industry ContainersPackaging

Profile
Details
Industry
Containers Or Packaging
Address
14025 Riveredge Drive
Phone
+1 215 698-5100
Employees
25000
Web
https://www.crowncork.com
Interact to see
Advertisement
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.